The DOI matches its Crossref record; 73 of the 76 references it cites were found in a registry or an index.
A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
Open accessAbstract
Surface-exposed calreticulin (ecto-CRT) and secreted ATP are crucial damage-associated molecular patterns (DAMPs) for immunogenic apoptosis. Inducers of immunogenic apoptosis rely on an endoplasmic reticulum (ER)-based (reactive oxygen species (ROS)-regulated) pathway for ecto-CRT induction, but the ATP secretion pathway is unknown. We found that after photodynamic therapy (PDT), which generates ROS-mediated ER stress, dying cancer cells undergo immunogenic apoptosis characterized by phenotypic maturation (CD80(high), CD83(high), CD86(high), MHC-II(high)) and functional stimulation (NO(high), IL-10(absent), IL-1β(high)) of dendritic cells as well as induction of a protective antitumour immune response. Intriguingly, early after PDT the cancer cells displayed ecto-CRT and secreted ATP before exhibiting biochemical signatures of apoptosis, through overlapping PERK-orchestrated pathways that require a functional secretory pathway and phosphoinositide 3-kinase (PI3K)-mediated plasma membrane/extracellular trafficking. Interestingly, eIF2α phosphorylation and caspase-8 signalling are dispensable for this ecto-CRT exposure. We also identified LRP1/CD91 as the surface docking site for ecto-CRT and found that depletion of PERK, PI3K p110α and LRP1 but not caspase-8 reduced the immunogenicity of the cancer cells. These results unravel a novel PERK-dependent subroutine for the early and simultaneous emission of two critical DAMPs following ROS-mediated ER stress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In line with a key role of CALR in the immunogenicity of RCD, the RNAi-mediated knockdown of CALR as well as natural defects in the CALR exposure pathway reportedly abolish the ability of dying cancer cells succumbing to anthracyclines to establish protective immunity in mice, whereas the exogenous provision of recombinant CALR confers immunogenic properties to otherwise non-immunogenic variants”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [883]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay‐Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,320
Photodynamic therapy of cancer: An update
Agostinis, P., Berg, K., Cengel, K. A., Foster, T. H., Girotti, A. W., Gollnick, S. O., Hahn, S. M., Hamblin, M. R., Juzeniene, A., Kessel, D., et al. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20114 · Cited by 5,145
Self-citationMinotti, G., Menna, P., Salvatorelli, E., Cairo, G., & Gianni, L. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.6 · Cited by 3,868
Calreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216
Photodynamic therapy and anti-tumour immunity
Castaño, A. P., Mróz, P., & Hamblin, M. R. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1894 · Cited by 2,685
STRING 8--a global view on proteins and their functional interactions in 630 organisms
Jensen, L. J., Kuhn, M., Stark, M., Chaffron, S., Creevey, C. J., Muller, J., Doerks, T., Julien, P., Roth, A. C., Simonovic, M., et al. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn760 · Cited by 2,475
Ghiringhelli, F., Apetoh, L., Tesniere, A., Aymeric, L., Ma, Y., Ortiz, C., Vermaelen, K., Panaretakis, T., Mignot, G., Ullrich, E., et al. (2009) · Nature Medicine · doi:10.1038/nm.2028 · Cited by 1,898
PI3K pathway alterations in cancer: variations on a theme
Yuan, T. L., & Cantley, L. C. (2008) · Oncogene · doi:10.1038/onc.2008.245 · Cited by 1,845
Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance
Elliott, M. R., Chekeni, F. B., Trampont, P. C., Lazarowski, E. R., Kadl, A., Walk, S. F., Park, D., Woodson, R. I., Ostankovich, M., Sharma, P., et al. (2009) · Nature · doi:10.1038/nature08296 · Cited by 1,654
Gardai, S. J., McPhillips, K. A., Frasch, S. C., Janssen, W. J., Starefeldt, A., Murphy-Ullrich, J. E., Bratton, D. L., Oldenborg, P.-A., Michalak, M., & Henson, P. M. (2005) · Cell · doi:10.1016/j.cell.2005.08.032 · Cited by 1,473
Flagged first, then by citations
3 of the 76 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Vergely C, Delemasure S, Cottin Y, Rochette L (2007) Preventing the cardiotoxic effects of anthracyclines: from basic concepts to clinical data. Heart Metab 35: 1–7
Cited by
Sorted by citations
Items 601–700 of 800
Mankor, J. M., Zwierenga, F., Dumoulin, D. W., Neefjes, J., & Aerts, J. G. J. V. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.06.029 · Cited by 8
Cold atmospheric plasma combined with nanoparticles in cancer therapy
Wang, Y., Cao, F., Martins, G. A., Fang, Q., Lin, Y., Chen, Z., Chen, G., & Chen, Z. (2025) · Interdisciplinary medicine · doi:10.1002/inmd.20250021 · Cited by 8
Mbah, N. E., Sutton, D., Hong, H. S., Singhal, R., Menjivar, R. E., Perricone, M. D., Giza, H., Sajjakulnukit, P., Myers, A. L., Nwosu, Z. C., et al. (2026) · Cancer & Metabolism · doi:10.1186/s40170-026-00428-3 · Cited by 7
Ma, G., Li, Y., Li, X., Yu, D., Chao, M., Li, J., Guo, J., Wang, K., Liu, Y., Sun, R., et al. (2026) · ACS Nano · doi:10.1021/acsnano.6c00358 · Cited by 8
Necroptosis, the Other Main Caspase-Independent Cell Death
Zanetti, L. C., & Weinlich, R. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-62026-4_7 · Cited by 7
Kimura, Y., Aoki, H., Soyama, T., Sakuragi, A., Otsuka, Y., Nomoto, A., Yano, S., Nishie, H., Kataoka, H., & Aoyama, M. (2022) · Medical Oncology · doi:10.1007/s12032-022-01674-3 · Cited by 7
Tumor cell surface modification with immuno-amplified nanoparticles to enhance cancer immunotherapy
Zhao, X., Liu, Q., Zheng, C., Wang, Y., Zhao, Y., Zhang, Z., Hao, J., Zheng, Y., Wang, C., & Liu, Y. (2022) · Materials Today Chemistry · doi:10.1016/j.mtchem.2022.101303 · Cited by 7
Jiang, A., Wang, M., Liu, H., Liu, S., Song, X., Zou, Y., Deng, Y., Qin, Q., Song, Y., & Zheng, Y. (2023) · MedComm – Oncology · doi:10.1002/mog2.33 · Cited by 7
Calreticulin: a quintessential multifaceted protein with therapeutic potential
Bansal, S., Vachher, M., & Burman, A. (2023) · Journal of Proteins and Proteomics · doi:10.1007/s42485-023-00111-x · Cited by 7
Longva, A. S., Berg, K., & Weyergang, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1278000 · Cited by 7
Li, H., Lu, J., Tan, S., Jiang, T., He, X., Qiao, W., Hu, C., Dalangood, S., Lin, J., & Gui, J. (2025) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-24-0834 · Cited by 8
Sioud, M., Juzenas, P., Zhang, Q., Kleinauskas, A., & Peng, Q. (2021) · Cancers · doi:10.3390/cancers13133356 · Cited by 7
High-mobility group box 1 protein contributes to the immunogenicity of rTcdB-treated CT26 cells
Gu, H., Ji, L., Chen, S., Qi, H., Shi, K., Li, S., Ma, Y., & Wang, J. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmy078 · Cited by 7
Bai, X., Zhou, Y., Lin, Q., Huang, C., Zhang, S., Carlson, R. I., Ghanbari, H., Sun, B., Wands, J. R., & Dong, X. (2021) · PubMed Central · Cited by 7
Breaking the Resistance: Photodynamic Therapy in Cancer Stem Cell-Driven Tumorigenesis
Rajan, S. S., Merlin, J. P. J., & Abrahamse, H. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17050559 · Cited by 6
Kah, G., & Abrahamse, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1633953 · Cited by 7
Kang, Y., Chen, Y., Yu, L., Zhao, J., Chen, G., Mou, X., Tong, X., & Cai, Y. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.217131 · Cited by 7
Sun, Y., Lu, Z., Taylor, J. A., & Au, J. L. ‐. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.11.023 · Cited by 6
Gabrysiak, M., Wachowska, M., Barankiewicz, J., Pilch, Z., Ratajska, A., Skrzypek, E., Winiarska, M., Domagała, A., Rygiel, T. P., Józkowicz, A., et al. (2016) · Oncology Reports · doi:10.3892/or.2016.4723 · Cited by 6
Self-citationYang, J. Y., Hu, S., Shangguan, J., Eresen, A., Li, Y., Ma, Q., Yaghmai, V., Benson, A. B., & Zhang, Z. (2020) · PubMed Central · Cited by 6
Proteotoxicity and endoplasmic reticulum stress-mediated cell death
Wang, M., Law, M. E., & Law, B. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-814208-0.00006-3 · Cited by 7
Long, S., Zhao, Y., Xu, Y., Li, H., Zhao, H., Chen, D., Zeng, J., Qiu, H., Li, X., & Gu, Y. (2022) · Journal of Innovative Optical Health Sciences · doi:10.1142/s1793545822400028 · Cited by 6
Stam, A. G. M., & de Gruijl, T. D. (2017) · Springer eBooks · doi:10.1007/978-3-319-55113-5_17 · Cited by 7
Mouskeftara, T., Goulas, A., Ioannidou, D., Ntenti, C., Agapakis, D. I., Assimopoulou, A. N., & Gika, H. (2021) · Metabolites · doi:10.3390/metabo11020090 · Cited by 6
Huang, Q., Zhang, Z., Zhao, Y., Cao, X., Li, Q., Feng, N., Wu, X., Wang, C., Xiao, J. Z., Shi, L., et al. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202420278 · Cited by 5
Ferroptosis induction enhances anti-PD-1 efficacy in NSCLC via HIF-1α/PD-L1 modulation
Wang, Z., Liu, H., Liang, J., Zhang, Y., Cho, W. C. S., Ye, M., Ma, D., Kong, M., Zhu, C., Shen, J., et al. (2026) · Translational Oncology · doi:10.1016/j.tranon.2026.102685 · Cited by 5
Liu, S., Yang, Z., Wang, B., Huan, S., Li, Z., Wei, X., & Liu, G. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104075 · Cited by 5
Liu, Z., Xu, X., Wang, M., Zhang, J., Zhao, X., Wang, M., Liu, F., & Liu, Z. (2026) · Cell Death Discovery · doi:10.1038/s41420-026-03012-2 · Cited by 5
Liu, Z., Wan, R., Bai, H., & Wang, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1104560 · Cited by 6
Wang, T., Wang, Y., Liu, T., Yu, F., Liu, L., Xiong, H., Xu, W., Fan, X., Liu, X., Jiang, H., et al. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202302767 · Cited by 6
Yin, Q., Song, Q., Sun, L., Lü, J., & Zhang, X. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118122 · Cited by 5
de Souza, F. G., de Lima, N. R. B., Roullin, G., Pal, K., & da Silva, N. D. (2021) · Current Radiopharmaceuticals · doi:10.2174/1874471014999210128183231 · Cited by 5
Ping, L., He, Y., Gao, Y., Wang, X., Huang, C., Bai, B., & Huang, H. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12111840 · Cited by 5
Gilstrap, S. R., Hobson, J. M., Owens, M. A., White, D. M., Sammy, M. J., Ballinger, S. W., Sorge, R. E., & Goodin, B. R. (2023) · Molecular Pain · doi:10.1177/17448069231195975 · Cited by 16
Lin, W., Liu, Y., Wang, J., Zhao, Z., Lǚ, K., He, M., Luoliu, R., He, X., Shen, J., Mao, Z., et al. (2023) · Angewandte Chemie · doi:10.1002/ange.202310158 · Cited by 5
Li, Q., Li, Y., Yang, Y., Dong, P., Mei, C., Lu, J.-L., Zhang, J., Hua, H.-Y., Xiong, C., Yu, C.-X., et al. (2023) · Parasitology · doi:10.1017/s0031182023001361 · Cited by 5
Immunogenic Stress and Death of Cancer Cells in Natural and Therapy-Induced Immunosurveillance
Kepp, O., Pol, J. G., Zitvogel, L., & Kroemer, G. (2017) · Springer eBooks · doi:10.1007/978-3-319-62431-0_12 · Cited by 6
Curcumin induces immunogenic cell death in murine colorectal carcinoma CT26 cells
Ganassin, R., Oliveira, G. R. T., da Rocha, M. C. O., Morais, J. A. V., Rodrigues, M. C., Motta, F. N., Azevedo, R. B., & Muehlmann, L. A. (2022) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2022.100046 · Cited by 5
Fong, W., Yeung, H., Lo, P., & Ng, D. K. P. (2017) · Springer eBooks · doi:10.1007/978-94-007-5052-4_35 · Cited by 5
Cancer Therapy-Induced Inflammation and Its Consequences
Saito, R. D. F., Rangel, M. C., Chandler, M. R., Beasock, D., Afonin, K. A., & Chammas, R. J. (2023) · Interdisciplinary biotechnological advances · doi:10.1007/978-981-19-8342-9_4 · Cited by 5
Zhang, Z., Cui, H., Zhang, T., Zhang, M., Wu, L., Zhang, X., Zhou, X., Li, X., Zhai, Y., Lu, Z., et al. (2023) · Materials & Design · doi:10.1016/j.matdes.2023.112067 · Cited by 5
Suváková, M., Majerník, M., Jendželovský, R., Hovan, A., Bánó, G., Fedoročko, P., & Antalı́k, M. (2020) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2020.111855 · Cited by 5
Yang, Z., Wang, L., & Kang, F. (2025) · International Journal of Cancer · doi:10.1002/ijc.35496 · Cited by 4
CX3CL1: a key switch of cell death immunogenicity
Demuynck, R., Naessens, F., & Krysko, D. V. (2025) · Trends in cancer · doi:10.1016/j.trecan.2025.08.008 · Cited by 4
Self-citationShah, N., Quaye, M. B., Soma, S. R., Vadlamudi, M. S., Mahmoud, D., Malkoochi, A., Aileni, T. R., Bhandari, C., Karambelkar, K., Hasan, T. G., et al. (2025) · Small Science · doi:10.1002/smsc.202500290 · Cited by 4
de Moraes, E. C., Silva, L. D. C., de Curcio, J. S., Graça, A. M., Batista, A. A., Silveira-Lacerda, E. D. P., & Gonçalves, P. J. (2025) · ACS Omega · doi:10.1021/acsomega.5c09619 · Cited by 4
Immunogenic cell death as a cornerstone for combination therapies with immune checkpoint blockade
Niu, Y., Zhu, S., Fu, K., Lai, Y. Y., Pan, C., Yang, Y., Li, S., Wang, X., To, K. F., Wang, F., et al. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02663-0 · Cited by 4
The Concept of Immunogenic Cell Death in Antitumor Immunity
Fucikova, J. P., Bartůňková, J., & Špíšek, R. (2015) · Klinicka onkologie · doi:10.14735/amko20154s48 · Cited by 4
Prologue: About DAMPs, PAMPs, and MAMPs
Land, W. G. (2018) · Springer eBooks · doi:10.1007/978-3-319-78655-1_11 · Cited by 5
Yang, R., Zhou, S., & Zhou, Q. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.03.003 · Cited by 4
Chemokine-targeted nanoparticles: stimulation of the immune system in cancer immunotherapy
Singh, R. K., Srivastava, P., & Manna, P. P. (2023) · Exploration of Immunology · doi:10.37349/ei.2023.00093 · Cited by 4
Liu, Z., Luo, Y., Su, L., & Hu, X. (2023) · Medicine · doi:10.1097/md.0000000000034571 · Cited by 4
Aindelis, G., Glaros, V., Fragkoulis, K., Mouchtari, A., Spyridopoulou, K., & Chlichlia, K. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10330-3 · Cited by 4
Radiation Therapy as a Modality to Create Abscopal Effects: Current and Future Practices
Adjepong, D., & Malik, B. H. (2020) · Cureus · doi:10.7759/cureus.7054 · Cited by 4
Wang, H., Jie, J., & Wang, X. (2015) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2015.07.009 · Cited by 4
Garg, A. D., Krysko, D. V., Vandenabeele, P., & Agostinis, P. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2162-8 · Cited by 4
Self-citationManipulating Cell Death in Cancer
Al-Janabi, I. I. (2025) · Al-Rafidain Journal of Medical Sciences · doi:10.54133/ajms.v9i1.2131 · Cited by 3
Xu, X., & Li, X. (2025) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s545150 · Cited by 3
Sharkawy, S., Acharya, S., Kostrhunová, H., Maji, M., Marková, L., Novohradský, V., Gibson, D., & Brabec, V. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01858 · Cited by 3
Huo, Y., Wang, Z., Zhu, X. H., Lu, Y., Jin, S., Wu, X., Zhang, H., Tan, G., & jin, Y. (2026) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2026.140259 · Cited by 3
Lou, F., Wei, Q., Yin, Y., Liu, S., He, Z., Tan, S., Gao, J., Dong, Z., Xu, Y., Li, Z., et al. (2025) · ACS Applied Nano Materials · doi:10.1021/acsanm.5c02778 · Cited by 3
Land, W. G. (2018) · Springer eBooks · doi:10.1007/978-3-319-78655-1_19 · Cited by 3
Sourcing the immune system to induce immunogenic cell death in Kras-colorectal cancer cells
Cirone, M., Lotti, L. V., Granato, M., Renzo, L. D., Biunno, I., Cattaneo, M., Verginelli, F., Vespa, S., Davies, D. C., Wells, V. E., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0561-z · Cited by 3
Prospect for immunological therapies of the equine malignant melanoma
Cavalleri, J. V., Mählmann, K., Schuberth, H. J., & Feige, K. (2015) · Pferdeheilkunde Equine Medicine · doi:10.21836/pem20150504 · Cited by 3
Oncolytic Viruses as Immunotherapeutic Agents
Trehub, Y., & Havrilov, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-50287-4_27 · Cited by 3
Wang, Y., Huang, Y., Yang, M., Yu, Y., Chen, X., Ma, L., Xiao, L., Liu, C., Liu, B., & Yuan, X. (2022) · Cancers · doi:10.3390/cancers14235952 · Cited by 3
Wen, Y., You, D., Bai, Y., Cao, J., Zhang, L., & Xia, X. (2023) · PubMed Central · Cited by 3
Pham, L. B. H., Chung, K. L., Kim, S., & Lee, J. (2023) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2023.134799 · Cited by 3
MHY1485 potentiates immunogenic cell death induction and anti-cancer immunity following irradiation
Sun, L., Morikawa, K., Sogo, Y., & Sugiura, Y. (2024) · Journal of Radiation Research · doi:10.1093/jrr/rrad107 · Cited by 3
Endogenous DAMPs, Category III: Inducible DAMPs (Cat. III DAMPs)
Land, W. G. (2018) · Springer eBooks · doi:10.1007/978-3-319-78655-1_14 · Cited by 3
Lotsberg, M. L., Chen, S., Dhakal, S., Lorens, J. B., Baguley, B. C., Chouaı̈b, S., & Engelsen, A. S. T. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819609-0.00008-0 · Cited by 3
Immunogenic Cell Death and Emission of Damps: Calreticulin and ATP
Krysko, D. V. (2012) · Journal of Nanomedicine & Biotherapeutic Discovery · doi:10.4172/2155-983x.1000e118 · Cited by 3
Self-citationCell-Autonomous (Cell-Intrinsic) Stress Responses
Land, W. G. (2018) · Springer eBooks · doi:10.1007/978-3-319-78655-1_18 · Cited by 4
Tümörogenezisde endoplazmik retikulum stres cevabının rolü
Evyapan, G., Gülsevinç, A. Y., Cömertpay, G., & Lüleyap, H. Ü. (2019) · Çukurova medical journal (Online)/Çukurova medical journal · doi:10.17826/cumj.480539 · Cited by 3
PERK interacts with FLNA to regulate ER-PM contact sites
van Vliet, A. R., & Agostinis, P. (2017) · Oncotarget · doi:10.18632/oncotarget.22384 · Cited by 3
Self-citationDevelopment of therapeutic cancer vaccines based on cancer immunity cycle
Zhang, J., Zheng, Y., Xu, L., Gao, J., Ou, Z., Zhu, M., & Wang, W. (2025) · Frontiers of Medicine · doi:10.1007/s11684-025-1134-6 · Cited by 2
Qiu, X., Liu, J., Song, L., Yu, H., Wu, Y., Wang, Q., Lu, M., Gu, X., Chen, B., Zhang, M., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.147397 · Cited by 2
Zhang, J., Li, Y., Fang, H., Dai, Y., Li, D., Li, L., Zuo, S., Liu, T., Sun, Y., Li, X., et al. (2025) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2025.102983 · Cited by 2
Zhang, H., Li, G., Chen, C., Ding, J., Shen, H., Min, W., & Yang, P. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c02668 · Cited by 2
Liu, Q., Zeng, X., He, Y., Zhou, L., Tang, Y., Liu, S., Wang, X., Shen, S., Ji, J., Liu, Z., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1788149 · Cited by 2
DANGER THEORY AND DAMAGE-ASSOCIATED MOLECULAR PATTERN
Poniewierska-Baran, A., Tokarz–Deptuła, B., & Deptuła, W. (2018) · Postępy Mikrobiologii - Advancements of Microbiology · doi:10.21307/pm-2018.57.4.328 · Cited by 2
Immunological effects of nano-enabled hyperthermia for solid tumors: opportunity and challenge
Liu, X., Sun, H., Wang, X., & Meng, H. (2021) · Frontiers of Chemical Science and Engineering · doi:10.1007/s11705-021-2059-5 · Cited by 2
Shields, N. J., Peyroux, E. M., Campbell, K., Mehta, S. Y., Woolley, A. G., Counoupas, C., Neumann, S., & Young, S. L. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2100500 · Cited by 2
Lin, X., Mao, D., & Bai, R. (2022) · PubMed Central · doi:10.12122/j.issn.1673-4254.2022.12.06 · Cited by 2
Immunogenic Cell Death in Cancer
Humeau, J., Naour, J. L., Kroemer, G., & Pol, J. G. (2023) · Interdisciplinary cancer research · doi:10.1007/16833_2022_121 · Cited by 2
A Systemic Review on Photodynamic Therapy: Emerging Technology with Healing Process
Varshney, P., Kumar, Y., Yadav, D., Singh, A., Kagithala, N. R., Sharma, P. K., Porwal, O., Fuloria, N. K., Sharma, P., Gupta, A. K., et al. (2023) · Current Cancer Therapy Reviews · doi:10.2174/0115733947263042230920040145 · Cited by 2
Park, J. H., Kim, M., Yun, D. H., & Kim, Y. (2023) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c00581 · Cited by 2
Yurttas, C., Horvath, P., Fischer, I. U., Wagner, S., Thiel, K., Ladurner, R., Königsrainer, I., Königsrainer, A., Schwab, M. G., Beckert, S., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13082422 · Cited by 2
Yao, Y., Zhang, Q., Wei, S., Li, H., Zhou, T., Zhang, Q., Zhang, J., Zhang, J., & Wang, H. (2024) · Translational Cancer Research · doi:10.21037/tcr-23-2243 · Cited by 2
In vitro evaluation of the immunogenic potential of gramicidin S and its photocontrolled analogues
Horbatok, K., Semchuk, I., Gorbach, O. I., Khranovska, N., Kosach, V., Borysko, P., Koniev, S., Ulrich, A. S., Afonin, S., & Komarov, I. V. (2025) · RSC Medicinal Chemistry · doi:10.1039/d5md00075k · Cited by 2
Zhu, Y., Cai, K., Guo, L., Zhang, H., Guan, L., Zhang, Z., Huang, P., & Yang, S. (2025) · Discover Oncology · doi:10.1007/s12672-025-02315-7 · Cited by 3
Colbert, L. E., & Jhingran, A. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-41008-7_9 · Cited by 2
Garg, A. D., & Agostinis, P. (2014) · Resistance to targeted anti-cancer therapeutics · doi:10.1007/978-3-319-12730-9_4 · Cited by 2
Self-citationWadhawan, M., Ahmad, F., Yadav, S., & Rathaur, S. (2022) · The Protein Journal · doi:10.1007/s10930-022-10080-7 · Cited by 2
A Novel Immunogenic Cell Death Inducer Based on Bimetallic Ferrocene Substituted Organotin Complexes
He, X., Xu, M., Liu, X., & Wang, Y. (2023) · ChemistrySelect · doi:10.1002/slct.202300464 · Cited by 2
Contribution of ER Stress to Immunogenic Cancer Cell Death
Garg, A. D., Krysko, D. V., Gołąb, J., Vandenabeele, P., & Agostinis, P. (2012) · Springer eBooks · doi:10.1007/978-94-007-4351-9_18 · Cited by 2
Self-citationRethinking Platinum Anticancer Drug Design: Towards Targeted and Immuno-chemotherapeutic Approaches
Wong, D. Y. Q. (2018) · Springer theses · doi:10.1007/978-981-10-8594-9 · Cited by 2
Rufo, N., Korovesis, D., Eygen, S. V., Derua, R., Garg, A. D., Finotello, F., Vara‐Pérez, M., Jan, R., Michael, D. S., de Witte, P. A. M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.24.424330 · Cited by 2
Self-citationMechanisms of triggering antitumor immunity: from photodynamic effects to immunogenic cell death
Sleptsova, E. E., Redkin, T. S., Saviuk, M. O., & Turubanova, V. D. (2024) · Genes and Cells · doi:10.17816/gc546129 · Cited by 1
Optimization of tumor photodynamic therapy strategies based on nanotechnology
Liu, Q., & Yu, R. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107202 · Cited by 1
Metadata
- Authors
- Garg, A. D., Krysko, D. V., Verfaillie, T., Kaczmarek, A., Ferreira, G. B., Marysael, T., Rubio, N., Firczuk, M., Mathieu, C., Roebroek, A. J. M., Annaert, W., Golab, J., de Witte, P., Vandenabeele, P., & Agostinis, P.
- Affiliations
- KU Leuven (BE)
- Vlaams Instituut voor Biotechnologie (BE)
- Corresponding author
- Agostinis, Patrizia
- ORCID
- Venue
- The EMBO Journal
- Published
- 2012-01-17
- Volume
- 31
- Issue
- 5
- Pages
- 1062-1079
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC3298003
- OpenAlex
- W1942176190
- Cited by
- 800
- References
- 76
- Citations by year
- 2026: 43 · 2025: 46 · 2024: 50 · 2023: 80 · 2022: 74 · 2021: 74 · 2020: 72 · 2019: 54 · 2018: 53 · 2017: 45 · 2016: 49 · 2015: 53 · 2014: 46 · 2013: 35 · 2012: 25
- FWCI
- 24.08
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- The EMBO Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Lirias (submittedVersion)
- Funders
- University of Alberta
- European Commission (200767)
- Fundacja na rzecz Nauki Polskiej
- Fonds De La Recherche Scientifique - FNRS
- Fonds Wetenschappelijk Onderzoek (G.0529.08)
- KU Leuven (GOA/11/009)
- Universiteit Gent (01M00709)
- Servier
- Vlaamse regering (BOF09/01M00709)
- European Regional Development Fund (POIG. 01.01.02-00-008/08)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- calreticulin, ATP release, immunogenic cancer cell death, photodynamic therapy, reactive oxygen species, endoplasmic reticulum stress, PERK, phosphatidylinositol 3-kinase, damage-associated molecular patterns, dendritic cell maturation, antitumor immunity, caspase-8, eIF2α phosphorylation, secretory pathway
- MeSH terms
- CD83 Antigen, Adenosine Triphosphate, Histocompatibility Antigens Class II, Cell Line, Dendritic Cells, Endoplasmic Reticulum, Humans, Immunoglobulins, Membrane Glycoproteins, Neoplasms, Antigens, CD, Cell Death, Photosensitizing Agents, Reactive Oxygen Species, B7-1 Antigen, Calreticulin, B7-2 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review